Skip to contentC
ClearPoint Neuro, Inc.
C
CLPTClearPoint Neuro, Inc. Q3 2020 · 10-Q
Revenue$3.52M$3.52M+20.2% vs Q3 2019 Net Income-$1.48M-$1.48MN/M vs Q3 2019 EPS Diluted-$90.00-$90.00N/M vs Q3 2019 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ClearPoint Neuro, Inc. · CIK 1285550 · Engraved from SEC EDGAR
Operating Cash Flowderived-$1,367,000N/M Margins · derivedGross margin74.3%
Operating margin-36.1%−5.0 pt vs Q3 2019
Net margin-42.2%−3.8 pt vs Q3 2019
ended Sep 30, 2020 · filed Nov 12, 2020 · 43 d after period end